Barrow Hanley Mewhinney & Strauss LLC lowered its position in shares of M.D.C. Holdings, Inc. (NYSE:MDC) by 22.8% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 117,286 shares of the construction company’s stock after selling 34,661 shares during the quarter. Barrow Hanley Mewhinney & Strauss LLC owned about 0.19% of M.D.C. worth $3,297,000 as of its most recent filing with the SEC.
Several other large investors have also recently modified their holdings of MDC. Zurcher Kantonalbank Zurich Cantonalbank grew its stake in shares of M.D.C. by 25.8% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,326 shares of the construction company’s stock worth $93,000 after purchasing an additional 683 shares in the last quarter. Bank of Montreal Can grew its stake in shares of M.D.C. by 14.1% in the fourth quarter. Bank of Montreal Can now owns 4,908 shares of the construction company’s stock worth $138,000 after purchasing an additional 605 shares in the last quarter. Meeder Asset Management Inc. bought a new position in shares of M.D.C. in the fourth quarter worth $173,000. Magnus Financial Group LLC bought a new position in shares of M.D.C. in the fourth quarter worth $208,000. Finally, Quantbot Technologies LP bought a new position in shares of M.D.C. in the third quarter worth $235,000. Institutional investors and hedge funds own 84.61% of the company’s stock.
Shares of NYSE MDC traded up $0.13 during mid-day trading on Friday, hitting $31.34. 190,360 shares of the company traded hands, compared to its average volume of 318,634. M.D.C. Holdings, Inc. has a 1 year low of $25.14 and a 1 year high of $33.47. The company has a market cap of $1.92 billion, a price-to-earnings ratio of 8.54, a P/E/G ratio of 1.18 and a beta of 1.33. The company has a quick ratio of 2.49, a current ratio of 9.15 and a debt-to-equity ratio of 0.70.
Several research firms have recently issued reports on MDC. Zacks Investment Research raised M.D.C. from a “hold” rating to a “buy” rating and set a $35.00 price target for the company in a research note on Wednesday, April 10th. ValuEngine cut M.D.C. from a “hold” rating to a “sell” rating in a research note on Tuesday, January 22nd. Two equities research analysts have rated the stock with a sell rating, one has assigned a hold rating and six have issued a buy rating to the stock. M.D.C. has an average rating of “Hold” and a consensus price target of $34.00.
In other news, COO David D. Mandarich sold 55,000 shares of the firm’s stock in a transaction dated Monday, February 25th. The stock was sold at an average price of $29.65, for a total transaction of $1,630,750.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director David Siegel sold 2,900 shares of the stock in a transaction dated Thursday, March 7th. The shares were sold at an average price of $28.18, for a total value of $81,722.00. The disclosure for this sale can be found here. Over the last three months, insiders sold 194,089 shares of company stock valued at $5,611,678. Company insiders own 26.30% of the company’s stock.
COPYRIGHT VIOLATION WARNING: This news story was originally published by Baseball Daily News and is owned by of Baseball Daily News. If you are accessing this news story on another publication, it was illegally stolen and reposted in violation of United States and international copyright & trademark law. The correct version of this news story can be viewed at https://www.baseballdailydigest.com/news/2019/04/21/m-d-c-holdings-inc-mdc-shares-sold-by-barrow-hanley-mewhinney-strauss-llc.html.
M.DC Holdings, Inc, through its subsidiaries, engages in the homebuilding and financial service businesses. Its homebuilding operations include purchasing finished lots or developing lots for the construction and sale primarily of single-family detached homes to first-time and first-time move-up homebuyers under the Richmond American Homes name.
Featured Article: What does the Dow Jones Industrial Average (DJIA) measure?
Receive News & Ratings for M.D.C. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for M.D.C. and related companies with MarketBeat.com's FREE daily email newsletter.